Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Pharmaceutical CofiledCriticalWarner Lambert Pharmaceutical Co
Publication of ES223297A1publicationCriticalpatent/ES223297A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Improvements introduced in the preparation of a therapeutic composition, characterized in that it comprises a compound having the formula: ** (See formula) ** wherein R represents an alkyl, hydroxyalkyl, aminoalkyl or cycloalkyl radical and R1 represents a methyl or ethyl radical, and a pharmacological carrier. (Machine-translation by Google Translate, not legally binding)
ES0223297A1954-08-021955-08-01A therapeutic composition (Machine-translation by Google Translate, not legally binding)
ExpiredES223297A1
(en)
Procedure for manufacturing and obtaining compounds and derivatives of benzotidyacine-1,1-dioxides (chlorotidates) (Machine-translation by Google Translate, not legally binding)